AeroDel Technology Innovations Pvt. Ltd., a Mumbai-based respiratory medical device company, announces an exclusive licensing arrangement with Zydus Lifesciences Limited for the commercial pan-India ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has launched Aerolife ...

Zydus Lifesciences announced the launch of Aerolife Mini, a next-generation pressurised metered-dose inhaler (pMDI) enhancer, marking a key step in the company's strategy to drive drug-device-led ...

A LOW COST ALTERNATIVE FOR COMMONLY USED ASTHMA MEDICATION WILL ENTER THE MARKET AFTER PRESSURE FROM SENATOR MAGGIE HASSAN ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...

Researchers from UCLA and other health institutions found that some inhalers produce significant greenhouse gas emissions, highlighting the need for health care providers to consider their carbon ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...